
N‐Phenylpropyl‐N′‐ (3‐methoxyphenethyl)piperazine (YZ‐185) …
2013年9月5日 · Previous locomotor activity experiments in mice determined that the sigma receptor ligand YZ-185 (N -phenylpropyl- N ′- (3-methoxyphenethyl)piperazine) enhanced …
Previous locomotor activity experiments in mice determined that the sigma receptor ligand YZ-185 (N-phenylpropyl-N -(3-methoxyphen-ethyl)piperazine) enhanced cocaine-induced hyperactivity …
Effects of N-phenylpropyl-N′-substituted piperazine sigma …
2013年9月1日 · YZ-067 was more effective than Nahas-3h to decrease cocaine’s effects. YZ-185 both inhibited and enhanced cocaine hyperactivity. The present study examined N …
N-phenylpropyl-N′-substituted piperazines occupy sigma …
2016年11月1日 · This study examined the effect of the N -phenylpropyl- N′-substituted piperazine ligands SA4503 (3.4-dimethoxyphenethyl), YZ-067 (4-methoxyphenethyl), YZ-185 (3 …
N-phenylpropyl-N'-substituted piperazines occupy sigma …
This study examined the effect of the N-phenylpropyl-N'-substituted piperazine ligands SA4503 (3.4-dimethoxyphenethyl), YZ-067 (4-methoxyphenethyl), YZ-185 (3-methoxyphenethyl) and …
N-Phenylpropyl-N'- (3-methoxyphenethyl)piperazine (YZ-185) …
2013年9月5日 · Previous locomotor activity experiments in mice determined that the sigma receptor ligand YZ-185 (N-phenylpropyl-N'- (3-methoxyphenethyl)piperazine) enhanced …
(PDF) N-Phenylpropyl-N′-(3-methoxyphenethyl)piperazine (YZ-185 ...
Overall, these results suggest that YZ-185 is a sigma receptor antagonist at the 31.6 μ mol/kg dose and demonstrate that sigma receptors can mediate the development of the conditioned …
YZ-185 (N-phenylpropyl-N -(3-methoxyphenethyl)pip-erazine), a structural congener to SA4503 in that it only lacks the 4-methoxy group on the phenethyl moiety, binds with high afinity...
爱赞助
We're sorry but azz-v2-frontend doesn't work properly without JavaScript enabled. Please enable it to continue. 爱赞助
N-Phenylpropyl-N′- (3-methoxyphenethyl)piperazine (YZ-185) …
2013年9月5日 · It is possible that YZ-185 functions as a sigma receptor antagonist at the higher dose and an agonist at the lower dose; demonstrating the characteristic mixed …